Submitted by Anonymous (not verified) on 15 April 2024 - 11:21
Human medicines European public assessment report (EPAR): Xospata, gilteritinib, Date of authorisation: 24/10/2019, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Xospata, gilteritinib, Date of authorisation: 24/10/2019, Revision: 6, Status: Authorised